Sotabase

Career

· Assistant Professor, NYU Courant2025–
· Senior Research Scientist, Google DeepMind2018–
· B.S. and M.Eng., MIT
· Postdoctoral Researcher, Stanford University
· PhD Student, UC Berkeley

Publications (173)

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.
Journal of Clinical Oncology · 2006
524
cited
Targeting notch signaling pathway in cancer: clinical development advances and challenges.
Pharmacology and Therapeutics · 2014
389
cited
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer.
Journal of Clinical Oncology · 2005
221
cited
Foundation Models for Decision Making: Problems, Methods, and Opportunities
arXiv.org · 2023
218
cited
New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer.
Cancer Treatment Reviews · 2016
218
cited
Compressing drug development timelines in oncology using phase '0' trials
Nature Reviews. Cancer · 2007
216
cited
Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes.
Journal of Clinical Oncology · 2007
174
cited
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors
Cancer Biology & Therapy · 2006
151
cited
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.
Journal of Proteome Research · 2008
136
cited
Cardiac Toxicity and Efficacy of Trastuzumab Combined with Pertuzumab in Patients with Trastuzumab-Insensitive Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
Clinical Cancer Research · 2008
132
cited
Designing Phase 0 Cancer Clinical Trials
Clinical Cancer Research · 2008
108
cited
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
Molecular Interventions · 2007
91
cited
Phase 0 Clinical Trials: Conceptions and Misconceptions
Cancer Journal · 2008
86
cited
The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.
Journal of Clinical Endocrinology and Metabolism · 2014
86
cited
Video as the New Language for Real-World Decision Making
International Conference on Machine Learning · 2024
84
cited
Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome
Oncogene · 2004
76
cited
Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
Oncology Report · 2007
64
cited
Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer.
Journal of Clinical Oncology · 2010
62
cited
DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer
Molecular Cancer Therapeutics · 2011
60
cited
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors
Cancer Chemotherapy and Pharmacology · 2015
60
cited
Sotabase
Sherry Yang | Researcher Profile | Sotabase | Sotabase